2011
DOI: 10.1016/j.vetmic.2010.11.001
|View full text |Cite
|
Sign up to set email alerts
|

Comparative genomic analysis of five pairs of virulent parental/attenuated vaccine strains of PRRSV

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
35
0
3

Year Published

2013
2013
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(39 citation statements)
references
References 34 publications
1
35
0
3
Order By: Relevance
“…To date, a number of type 2 PRRS MLV vaccines have been successfully employed in the global market. In addition, live attenuated candidate vaccines have been exploited by prolonged viral passages of the emerged HP-PRRSV isolates on MARC-145 cells and domestically implemented in China (An et al, 2011a;Han et al, 2009;Leng et al, 2012a,b;Tian et al, 2009). In the present study, we developed a PRRSV MLV vaccine candidate obtained by 100 passages of the virulent MN184-related nsp2 DEL strain CA-2 in MARC-145 cells and ascertained the pathogenic and genetic characteristics associated with the cell adaptation process.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…To date, a number of type 2 PRRS MLV vaccines have been successfully employed in the global market. In addition, live attenuated candidate vaccines have been exploited by prolonged viral passages of the emerged HP-PRRSV isolates on MARC-145 cells and domestically implemented in China (An et al, 2011a;Han et al, 2009;Leng et al, 2012a,b;Tian et al, 2009). In the present study, we developed a PRRSV MLV vaccine candidate obtained by 100 passages of the virulent MN184-related nsp2 DEL strain CA-2 in MARC-145 cells and ascertained the pathogenic and genetic characteristics associated with the cell adaptation process.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, the first type 2 live vaccine, Ingelvac PRRS MLV, was obtained by continuous passages in MARC-145 cells (Opriessnig et al, 2002). More recently, live attenuated HP-PRRSV vaccines were developed by in vitro serial passages in MARC-145 cells and are now available in Chinese markets, showing effectiveness and protection by reducing the economic loss against PRRS (An et al, 2011a;Han et al, 2009;Leng et al, 2012a,b;Tian et al, 2009). In the present study, the virulent Korean PRRSV nsp2 DEL strain CA2 was culturally passaged 100 times in MARC-145 cells for attenuation so that it could be further used for the development of an MLV vaccine.…”
Section: Introductionmentioning
confidence: 99%
“…Mutations associated with PRRSV attenuation had been revealed in several studies; the investigators suggested that multiplate regions would relate to the attenuation of PRRSV [18, 24, 3033]. In this study, a highly pathogenic PRRSV strain named QY1 P5 was passaged in vitro, and mutations occurred during this process, including 34 amino acid changes, 1 nucleotide deletion, and 34 amino acid deletions in the QY1 P100.…”
Section: Discussionmentioning
confidence: 93%
“…In the recent years, new NA type PRRSV variants called highly pathogenic strains (HP) has emerged in Vietnam and China causing large-scale outbreaks and destructive clinical syndromes [6,8] . Those HP-PRRSV isolates share high sequence identity and have similar deletions/mutations in difference regions of viral genome such as two deletions in non-structural protein 2, one deletion in the 5'-untranslated region, and one deletion in the 3' untranslated region, and some other point mutations [9] . Recently, several studies on genetic variation and phylogenetic relationship based on major structural genes of PRRSV isolates such as ORF5, ORF7 have been done [10][11][12][13][14] .…”
Section: Introductionmentioning
confidence: 99%